Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward
Despite the prevalence of opioid misuse, opioids remain the frontline treatment regimen for severe pain. However, opioid safety is hampered by side-effects such as analgesic tolerance, reduced analgesia to neuropathic pain, physical dependence, or reward. These side effects promote development of op...
Main Authors: | Mackenzie C. Gamble, Benjamin R. Williams, Navsharan Singh, Luca Posa, Zachary Freyberg, Ryan W. Logan, Stephanie Puig |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Systems Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnsys.2022.1059089/full |
Similar Items
-
The Downregulation of Opioid Receptors and Neuropathic Pain
by: Lin Li, et al.
Published: (2023-03-01) -
The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
by: Pilar Sánchez-Blázquez, et al.
Published: (2020-11-01) -
Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids
by: Xin-Yan Zhang, et al.
Published: (2020-06-01) -
New opioid analgesic tapentadol in the treatment of neuropathic pain in oncology
by: R. R. Sarmanaeva, et al.
Published: (2019-06-01) -
Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023-07-01)